Paris is not just the city of lights; it is one of the world's most sophisticated pharmaceutical and biotechnological clusters. The Île-de-France region, surrounding Paris, hosts a dense network of over 1,000 life sciences companies, ranging from multinational giants to specialized injectable drugs manufacturers.
Factories in the Paris region benefit from an ecosystem of world-class research hospitals (AP-HP), prestigious universities like Sorbonne, and the "Medicen Paris Region" cluster. This localized synergy ensures that injectable drugs produced here meet the most stringent EU-GMP (Good Manufacturing Practice) standards. From the manufacturing of sterile fill-finish injectables to the development of advanced oncology treatments, Paris stands at the forefront of medical innovation.
Proximity to the Plateau de Saclay ensures access to cutting-edge research in molecular biology and injectable drug delivery systems.
With Paris-Charles de Gaulle airport and extensive rail networks, sterile drugs are exported within hours to global markets.
Hangzhou Jeci Biochem Technology Co., Ltd. serves as a bridge between high-quality manufacturing and international medical needs. Located in the tech-driven hub of Zhejiang Province, we are committed to the sales of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and specialized injectable drugs.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Global Markets
R&D Partners
GMP Compliance
Technical Support
Transition from traditional vials to pre-filled syringes and auto-injectors for patient convenience.
Increasing demand for large-molecule injectables in Paris hospitals for chronic disease management.
Reducing carbon footprints in pharmaceutical factories through sustainable chemical engineering.
Integration of AI and machine vision in injectable production lines for zero-defect quality control.
Our drugs and intermediates are widely used across multiple sectors in the medical and industrial landscape of Paris and beyond:
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For our main product intermediates, we maximize our advantages to meet customer requirements within tight deadlines.
The Assistance Publique – Hôpitaux de Paris (AP-HP) is the largest hospital system in Europe. Our Indocyanine Green drugs and liver segment detection injectables are vital for precise surgical interventions and diagnostic imaging in Paris's top clinics. Accuracy in injectable diagnostics saves lives and reduces recovery times.
Beyond the city center, the French countryside relies on advanced veterinary care. Our range of veterinary injectable drugs, including Buparvaquone and Amoxicillin, supports livestock health in the farms surrounding Paris, ensuring food safety and animal welfare according to French agricultural standards.
Paris is home to world-renowned eye institutes. Our disposable injectable drugs for ophthalmic retinal surgery are designed for effortless storage and high sterility, meeting the precision requirements of Parisian surgeons performing complex intraocular procedures.
Paris serves as the primary gateway for pharmaceutical trade between Europe and Asia. Hangzhou Jeci Biochem leverages these trade routes to provide seamless registration, consulting, and sales channel expansion services for companies looking to bridge the Chinese and French medical markets.
Manufacturing or partnering with entities in Paris ensures compliance with EMA regulations and access to one of the most advanced biotech infrastructures in the world. The quality control standards for sterile injectables in France are among the highest globally.
We provide various solutions, including reliable room temperature injectable drugs for clinics with limited cold-chain infrastructure, as well as specialized storage solutions for delicate retinal surgery medications.
Yes, Hangzhou Jeci Biochem specializes in custom R&D and manufacturing. We work closely with research institutes to develop advanced intermediates tailored to specific clinical or industrial applications.
Whether you are based in Paris or looking to expand into the Chinese pharmaceutical market, our team is ready to provide technical support, product registration, and custom manufacturing services.
Connect With Us Today